$6.44
-0.06-0.92%
At close: -
$6.44
00.00%
After Hours: 4:02 PM EDT
Comments
Loading...
Acrivon Therapeutics (ACRV) Forecast
NewsEarningsAcrivon Therapeutics (ACRV) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAcrivon Therapeutics (NASDAQ:ACRV) Stock Quotes, Forecast and News Summary
Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acrivon Therapeutics (ACRV) stock?
You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.
Who are Acrivon Therapeutics (ACRV) competitors?
Other companies in Acrivon Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Inozyme Pharma (NASDAQ:INZY) and Zentalis Pharma (NASDAQ:ZNTL).
What is the forecast, or price target, for Acrivon Therapeutics (ACRV) stock?
Acrivon Therapeutics has a consensus price target of $22.67.
What is the current price for Acrivon Therapeutics (ACRV)?
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $6.44 last updated November 21, 2024 at 4:02 PM EST.
Does Acrivon Therapeutics (ACRV) pay a dividend?
There are no upcoming dividends for Acrivon Therapeutics.
When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?
Acrivon Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Acrivon Therapeutics (ACRV) going to split?
There is no upcoming split for Acrivon Therapeutics.
What sector and industry does Acrivon Therapeutics (ACRV) operate in?
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.